التفاصيل البيبلوغرافية
| العنوان: |
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections. |
| المؤلفون: |
Rebold, Nicholas, Morrisette, Taylor, Lagnf, Abdalhamid M, Alosaimy, Sara, Holger, Dana, Barber, Katie, Justo, Julie Ann, Antosz, Kayla, Carlson, Travis J, Frens, Jeremy J, Biagi, Mark, Kufel, Wesley D, Moore, William J, Mercuro, Nicholas, Raux, Brian R, Rybak, Michael J |
| المصدر: |
Open Forum Infectious Diseases; Dec2021, Vol. 8 Issue 12, p1-7, 7p |
| مستخلص: |
A multicenter case series of 21 patients were treated with imipenem-cilastatin-relebactam. There were mixed infection sources, with pulmonary infections (11/21,52%) composing the majority. The primary pathogen was Pseudomonas aeruginosa (16/21, 76%), and 15/16 (94%) isolates were multidrug-resistant. Thirty-day survival occurred in 14/21 (67%) patients. Two patients experienced adverse effects. [ABSTRACT FROM AUTHOR] |
|
Copyright of Open Forum Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder